All News

Researchers at the Duke Cancer Institute in Durham, NC say they have developed a tool to forecast the potential survival of individual prostate cancer patients, enabling physicians to better assess whether to try additional rounds of treatment or seek clinical trials.

The first phase II study to investigate the use of the targeted therapy everolimus (Afinitor) for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease.

Women with common forms of urinary incontinence have various bacteria in their bladder, according to a recent study, and some of these bacteria may differ based on their incontinence type.

In this interview, Dr. Samir S. Taneja discusses the AUA's recommendations on the optimal method to perform a prostate biopsy and handle specimens as well as how to minimize infection and the role of imaging.

Results from a study in an experimental model of cystitis point to the cannabinoid receptor 2 (CB2) as a potential target to develop effective new therapies for patients with painful bladder disorders.

Urinary measurement of inflammatory chemokines may offer a noninvasive method for evaluating treatment response to sacral neuromodulation (InterStim Therapy, Medtronic, Inc., Minneapolis) in patients with interstitial cystitis/painful bladder syndrome, says Michael Chancellor, MD.

Thulium vapoenucleation of the prostate provided significant and durable symptomatic improvement in benign prostatic obstruction, long-term follow-up of a clinical series showed.

Primary androgen deprivation therapy for localized prostate cancer is associated with significantly better survival outcomes in a Japanese cohort compared with an American population, according to a recent study.

In many cases, you have the option of recouping revenue from previous practices/business structures that you no longer report, as long as you can provide the data.

In this article, I examine and question the phenomenon of “the urine drop-off”-having the patient with suspected UTI collect a urine sample at home and drop it off at the practice-in the context of best clinical practice, common sense, and basic office efficiency.

Permanent insurance needs are met through varying types of whole life and universal life insurance policies designed to stay in force throughout one’s lifetime. Unlike term insurance, where premiums generally increase as the insured ages, most permanent life insurance premiums remain level.

"Do I think [ICD-10] will make patient care better? If it did, I would be really shocked. The question is, will it make patient care worse? I hope not.”

Single-fraction radiotherapy for bone metastases from prostate cancer is not widely used despite its comparable efficacy and lower cost in relation to multiple-fraction treatment, according to a recent study.

Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide similar tumor control and decreased late toxicity when compared to surgery, say the authors of a study from the United Kingdom.

While women are far more likely to suffer from urinary tract infections, men are more likely to be hospitalized for treatment, according to a study by urologists from Henry Ford Hospital in Detroit.

MDxHealth SA said its ConfirmMDx for Prostate Cancer test met all of the primary endpoints in a recently completed clinical validation trial.

The group practice of dedicated subspecialists can establish its position as a community center of excellence if it accepts the challenge and the need to modify historic practice concepts.

Data from a phase II study suggest that the potency of sipuleucel-T (Provenge) and immunologic prime-boost responses are maintained when the immunotherapy is administered concurrently or sequentially with abiraterone acetate (ZYTIGA) plus prednisone.

The search is on for drugs based on cannabis.

The latest products and services from Cook Medical, American Medical Systems, Dialog Medical, Astellas Pharma U.S., Giffen Solutions, the Société Internationale d’Urologie, Merck Consumer Care, and the Bladder Cancer Advocacy Network.

In this interview, Brian R. Matlaga, MD, MPH, discusses factors to consider in the decision to utilize ureteroscopy versus shock wave lithotripsy, how to counsel patients on the optimal approach, how to minimize the morbidity of each modality, and why younger urologists are more likely to perform ureteroscopy.

The bundled payment model for episodes of care is a major player in what could be sweeping changes to the physician payment system that will likely see traditional fee for service taper off. Bundling has already made inroads in some surgical specialties, and it may very well apply to inpatient urologic procedures as well.

This article discusses how urologists can help fill the need for surgical relief work, and offers some advice on ensuring your philanthropic trip is a successful one.

Drugs and devices in the pipeline from Auxilium Pharmaceuticals, Metamark Genetics, Endo Pharmaceuticals, Nymox Pharmaceutical Corp., VIVUS, and Sanofi Chimie.

While it is still unclear whether and how Congress will reform the Medicare sustainable growth rate formula in time to avoid a 25% payment cut beginning in January, many physician groups, including the AUA, are adamantly opposed to another key component of the proposed 2014 Medicare Physician Fee Schedule.

In its push to close the loophole on physician self-referral for prostate cancer treatment, the American Society for Radiation Oncology now has what some may call an unlikely ally.

Abiraterone acetate (ZYTIGA) significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone, the authors of a multicenter study reported.

Short-term hormone therapy appears to produce outcomes that are as favorable as those for long-term therapy in men with intermediate-risk prostate cancer, according to the results of two studies from the Radiation Therapy Oncology Group.